Category: Latest News

  • Cerus Shares Rise After DoD Awards Additional $7.2M for Trauma Blood Product Development

    Cerus Shares Rise After DoD Awards Additional $7.2M for Trauma Blood Product Development

    Cerus Corporation (NASDAQ:CERS) saw its stock climb 3.3% following news of a $7.2 million contract amendment from the U.S. Department of Defense (DoD). The new funding expands the company’s existing partnership with the DoD to advance development of its lyophilized, pathogen-reduced Cryoprecipitated Fibrinogen Complex (LyoIFC). This latest award builds upon nearly $18 million previously allocated…

  • Elevance Health Shares Touch 52-Week Low Amid Sector Headwinds and Medicaid Pressures

    Elevance Health Shares Touch 52-Week Low Amid Sector Headwinds and Medicaid Pressures

    Shares of Elevance Health Inc. (NYSE:ELV) dropped to a new 52-week low of $275.60, reflecting a turbulent year for the healthcare insurer as it grapples with operational challenges and macroeconomic pressures. Despite a market cap of $62.8 billion and a price-to-earnings ratio of 11.85 suggesting the stock may be undervalued relative to its estimated fair…

  • Sequans Communications Shares Rally After Adding Over $150M in Bitcoin to Treasury

    Sequans Communications Shares Rally After Adding Over $150M in Bitcoin to Treasury

    Shares of Sequans Communications S.A. (NYSE:SQNS) climbed 6.9% after the semiconductor firm disclosed a substantial addition to its Bitcoin holdings, signaling an expanded commitment to cryptocurrency as a treasury reserve asset. The company announced that it recently acquired 1,264 Bitcoin for about $150 million, with an average purchase price of approximately $118,659 per coin, including…

  • BTCS Shares Jump After Securing $10M Convertible Note Deal to Boost Ethereum Strategy

    BTCS Shares Jump After Securing $10M Convertible Note Deal to Boost Ethereum Strategy

    Shares of BTCS Inc (NASDAQ:BTCS) soared 11% after the blockchain-focused firm announced a $10 million convertible note financing agreement with ATW Partners LLC, further reinforcing its aggressive Ethereum investment strategy. The company said the newly arranged funding adds to its liquidity reserves, pushing the combined market value of its Ethereum holdings, cash, and other liquid…

  • Mobilicom Shares Climb After Locking in $1.4 Million U.S. Drone Orders

    Mobilicom Shares Climb After Locking in $1.4 Million U.S. Drone Orders

    Mobilicom Ltd ADR (NASDAQ:MOB) saw its stock jump 11.3% after the company announced it secured roughly $1.4 million in new orders from a major U.S.-based drone manufacturer. The cybersecurity and drone tech company said the orders came from an existing client described as a Tier-1 drone producer with more than $5 billion in annual revenue.…

  • Thomson Reuters Shares Edge Higher After Joining Nasdaq-100 Index

    Thomson Reuters Shares Edge Higher After Joining Nasdaq-100 Index

    Thomson Reuters Corp (NASDAQ:TRI) saw a modest 0.5% increase in premarket trading Monday following an announcement from Nasdaq that the company will be added to the Nasdaq-100 Index, one of the most prominent benchmarks in U.S. equity markets. The financial data and media company is set to replace ANSYS Inc. (NASDAQ:ANSS) in the Nasdaq-100 Index…

  • Oruka Therapeutics Shares Climb After FDA Greenlights Psoriasis Drug Trial

    Oruka Therapeutics Shares Climb After FDA Greenlights Psoriasis Drug Trial

    Oruka Therapeutics Inc (NASDAQ:ORKA) saw its stock rise 6.6% after revealing that the U.S. Food and Drug Administration (FDA) has approved its investigational new drug (IND) application to begin a Phase 2a clinical trial of its psoriasis drug, ORKA-001. The study, named EVERLAST-A, will test Oruka’s extended-duration anti-IL-23p19 antibody in roughly 80 patients suffering from…

  • Sarepta Shares Drop as FDA Suspends Gene Therapy Trials for Muscular Dystrophy

    Sarepta Shares Drop as FDA Suspends Gene Therapy Trials for Muscular Dystrophy

    Shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) plunged 10% after the company disclosed that the U.S. Food and Drug Administration (FDA) has imposed a clinical hold on several of its gene therapy programs targeting limb girdle muscular dystrophy (LGMD). The hold impacts a series of Sarepta’s experimental therapies, including SRP-9003, SRP-9004, SRP-6004, and SRP-9005. Notably, Sarepta…

  • SAB Biotherapeutics Shares Jump 33% After Securing $175M in Oversubscribed Private Placement

    SAB Biotherapeutics Shares Jump 33% After Securing $175M in Oversubscribed Private Placement

    SAB Biotherapeutics Inc (NASDAQ:SABS) saw its stock surge by 33% following the announcement of a $175 million private placement backed by a mix of strategic and institutional investors. The oversubscribed financing round was led by pharmaceutical giant Sanofi (NASDAQ:SNY) and joined by new investors such as RA Capital Management, Commodore Capital, Vivo Capital, and Blackstone’s…

  • U.S. Stocks Edge Higher as Investors Watch Earnings and Tariff Developments

    U.S. Stocks Edge Higher as Investors Watch Earnings and Tariff Developments

    U.S. stocks moved up slightly on Monday morning as investors looked ahead to a busy week of second-quarter earnings reports, with major firms set to announce results. By 9:35 a.m. ET: Markets had stalled near record highs last Friday amid reports that President Trump is pushing for new tariffs of at least 15% to 20%…